Weekly etoposide, methotrexate and actinomycin D, alternating with cyclophosphamide plus vincristine (EMA/CO): A phase II study in advanced gastric carcinoma
Authors:
- P.A. PhilipPPP.A. Philip
- G.J. RustinGRG.J. Rustin
- J.A. LedermannJLJ.A. Ledermann
- R.H.J. BegentRBR.H.J. Begent
- E.S. NewlandsENE.S. Newlands
- K.D. BagshaweKBK.D. Bagshawe
- 1 January 1991
- journal article
- Published by Elsevier in Clinical Oncology
- Vol. 3 (4) , 214-216